Clinical Trials Logo
  1. Home
  2. Recurrence
  3. NCT03949192
  4. Details
NCT03949192 Clinical Trial

Efficacy of Kangliuwan for Recurrent Grade IV Glioma

Recurrence Clinical Trial

Official title:
Efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma: A Prospective Exploratory Clinical Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03949192
Other study ID # LYS [2019] 027
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 28, 2019
Est. completion date June 2021

Study information
Verified date April 2020
Source Xuanwu Hospital, Beijing
Contact Qingtang Lin, MD. Ph.D
Phone 8610-83198362
Email linqingtang@xwhosp.orn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A Prospective Exploratory Clinical Study to explore the efficacy of Hospital Traditional Chinese Medicine Preparation Kangliuwan for Recurrent Grade IV Glioma.

Recruitment information / eligibility
Status Recruiting
Enrollment 20
Est. completion date June 2021
Est. primary completion date June 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. The patient signed "informed consent" voluntarily;

2. The age of patient is between 18 and 80 years;

3. KPS score =40 ; The patient has normal liver and kidney function Normal heart function Better follow-up and compliance;

Exclusion Criteria:

1. The patient did not sign "informed consent" or signed unvoluntarily.

2. Non-glioma patients

3. Active infection

4. Human immunodeficiency virus (HIV) positive

5. Hepatitis C or hepatitis B infective

6. Pregnancy or breast-feeding women

7. Patients did not agree to use effective contraception during treatment and the following 3 months.

8. Patients also participated in other clinical studies.

9. The subjects researchers believe are not suitable for participation or completion of the study.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Xuanwu Hospital Beijing Beijing

Sponsors (1)
Lead Sponsor Collaborator
Xuanwu Hospital, Beijing

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes in tumor volume the volume of tumor decreased after taking Kangliuwan 3 months
See also
  Status Clinical Trial Phase
Completed NCT03545659 - Childhood Acute Lymphoblastic Leukaemia: Follow-Up
Completed NCT04838613 - Study of Diagnostic Performance of [18F]CTT1057 in BCR Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Recruiting NCT04266600 - Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease N/A
Recruiting NCT04539665 - Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease. N/A
Terminated NCT03257722 - Pembrolizumab + Idelalisib for Lung Cancer Study Phase 1/Phase 2
Completed NCT01141335 - Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair Phase 4
Completed NCT00029185 - Study of Dehydrex in Patients With Corneal Erosion N/A
Completed NCT01351974 - Sentinel Node Biopsy in Breast Cancer Patients N/A
Not yet recruiting NCT06038422 - GTP Regimen in the Treatment of Refractory/Recurrent HLH Phase 3
Withdrawn NCT03162120 - Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation Phase 2/Phase 3
Recruiting NCT04159051 - Charité HT-Prostate N/A
Recruiting NCT02566928 - Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence Phase 4
Completed NCT01989845 - Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer Phase 4
Recruiting NCT01229475 - Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation N/A
Completed NCT00944554 - Relapse Prevention With Varenicline Phase 4
Terminated NCT02247258 - Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. Phase 2
Completed NCT03654209 - Post-resection Treatment of Large Colon Polyps N/A
Recruiting NCT05557474 - Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
Active, not recruiting NCT03865537 - Cold Snare Endoscopic Mucosal Resection Trial N/A